Clinical characteristics of patients with high-grade gliomas
| Patient | Age/Gender | Diagnosis/Grade | Tumor Location | Interscan Interval (months) | Interscan Treatment |
|---|---|---|---|---|---|
| 1 | 58/F | GBM WHO IV | Rt temporal | 3 | GTR |
| 2a | 73/F | AA WHO III | Lt temporal | 8 | – |
| 3 | 44/M | AGN WHO III/IV | Lt frontoparietal | 3 | BVZ |
| 4 | 62/F | GBM WHO IV | Rt temporal | 5 | BVZ |
| 5 | 50/M | OA WHO III | Lt temporal | 3 | STR + BVZ |
| 6 | 57/F | GBM WHO IV | Rt frontal | 5 | BVZ |
| 7 | 35/M | AA WHO III | Lt frontoparietal | 3 | Chemotherapy/XRT |
| 8 | 65/M | GBM WHO IV | Lt frontotemporal | 2 | STR + chemotherapy/XRT |
| 9 | 49/M | OA WHO III | Lt frontotemporal | 6 | Chemotherapy/XRT |
| 10b | 67/M | GBM WHO IV | Lt parietal | 1 | GTR + chemotherapy/XRT |
F indicates female; M, male; Lt, left; Rt, right; GBM, glioblastoma; AA, anaplastic astrocytoma; OA, oligoastrocytoma; AGN, anaplastic glioneural neoplasm; GTR, gross total resection; STR, subtotal resection; BVZ, bevacizumab; XRT, radiotherapy; WHO, World Health Organization.
↵a Chemotherapy/XRT was received 1 month prior to the initial scan.
↵b Newly diagnosed tumor at the time of the first scan. All other patients had recurrent tumor and surgical or medical management prior to the initial scan.